160 related articles for article (PubMed ID: 38737645)
1. [
Zhou P; Li Z; Li D; Xue S; Li R; Zhang L; Bai Q; Li X
Am J Nucl Med Mol Imaging; 2024; 14(2):122-133. PubMed ID: 38737645
[TBL] [Abstract][Full Text] [Related]
2.
Ren F; Jiang H; Shi L; Zhang L; Li X; Lu Q; Li Q
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2056-2067. PubMed ID: 36847824
[TBL] [Abstract][Full Text] [Related]
3. A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides.
Beyer D; Vaccarin C; Deupi X; Mapanao AK; Cohrs S; Sozzi-Guo F; Grundler PV; van der Meulen NP; Wang J; Tanriver M; Bode JW; Schibli R; Müller C
EJNMMI Res; 2023 Apr; 13(1):32. PubMed ID: 37074529
[TBL] [Abstract][Full Text] [Related]
4. ACE2 PET to reveal the dynamic patterns of ACE2 recovery in an infection model with pseudocorona virus.
Li X; Yin W; Li A; Li D; Gao X; Wang R; Cui B; Qiu S; Li R; Jia L; Zuo C; Zhang L; Li M
J Med Virol; 2023 Feb; 95(2):e28470. PubMed ID: 36606602
[TBL] [Abstract][Full Text] [Related]
5. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
[TBL] [Abstract][Full Text] [Related]
7. Imaging of human pancreatic cancer xenografts by single-photon emission computed tomography with
Zhang X; Tian YE; Sun F; Feng H; Yang C; Gong X; Tan G
Oncol Lett; 2015 Oct; 10(4):2253-2258. PubMed ID: 26622829
[TBL] [Abstract][Full Text] [Related]
8.
Shi L; Chen B; Liu T; Li L; Hu B; Li C; Jia B; Wang F
Mol Pharm; 2022 Jul; 19(7):2583-2594. PubMed ID: 35696536
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L
Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099
[TBL] [Abstract][Full Text] [Related]
10. Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.
Ji S; Zheng Y; Shao G; Zhou Y; Liu S
Theranostics; 2013; 3(11):816-30. PubMed ID: 24312152
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Imaging of Tumor PD-L1 Expression Using [
Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Preliminary Study of
Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
[TBL] [Abstract][Full Text] [Related]
14. [
Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of [
Liu T; Wu Y; Shi L; Li L; Hu B; Wang Y; Gao H; Yu X; Zhang X; Zhao H; Wan Y; Jia B; Wang F
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1810-1821. PubMed ID: 35013776
[TBL] [Abstract][Full Text] [Related]
16. The Distribution and Imaging of
Fan G; Wan R; Zhang B; Deng S; Peng M; Xue W; Xu L; Qin X; Wu Y
Cancer Biother Radiopharm; 2018 Dec; 33(10):445-459. PubMed ID: 30133308
[No Abstract] [Full Text] [Related]
17. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
[TBL] [Abstract][Full Text] [Related]
20. SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.
Luo X; Zhang Z; Cheng C; Wang T; Fang D; Zuo C; Yuan G; Li R; Li X
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]